RIGL vs SO · P/E 9.1, rev $179.3M vs P/E 22, rev $29.55B
Rigel Pharmaceuticals Inc (RIGL) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported RIGL revenue for 2024-12-31 was $179.3M. Net income was $17.5M. Revenue was up 53.4% from 2023-12-31 to 2024-12-31. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
RIGL currently screens at market cap $338.3M and trailing P/E 9.1. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the RIGL and SO stock pages for the full models.
Not investment advice.